A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

For individuals facing fear, uncertainty and repeated procedures associated with recurrent low-grade intermediate-risk bladder tumors, timely access to treatment can be critical. ZUSDURI, the first ...

A recent study reveals comparable outcomes for radical cystectomy and bladder-sparing therapy in treating recurrent ...

Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...

Patients recently diagnosed with cancer show an increased risk for major bleeding after myocardial infarction, with the risk ...

Pfizer Inc. (NYSE:PFE) is one of the most buzzing stocks to invest in according to hedge funds. Earlier on December 17, ...

While the current approval focuses on the second-line setting, research is already moving into earlier stages of the ...

US surgeons successfully performed the world's first human bladder transplant on 4 May 2025. The complicated, eight-hour procedure involved the retrieval of a kidney and bladder from an organ donor ...

James Stewart puts on his rollerblades to get ready to do the trail in Rabb Park on his day off. He continues to be able to ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

In-hospital deaths among patients hospitalized with bladder cancer in the United States increased from 2008 to 2021, suggesting more work needs to be done to prevent early death in this patient ...